DENDREON PHARMACEUTICALS, LLC

biopharmaceutical company that manufactures an immunotherapy for prostate cancer

1700 Saturn Way Seal Beach CA 90740, Seal Beach, CA  ·  DREW SAELENS

Filings
32
Clients
1
Total Income
Years Active
2019–2026

Filings

Year Client Period Income Expenses Doc
2026 DENDREON PHARMACEUTICALS, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$59,650
2025 DENDREON PHARMACEUTICALS, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$59,650
2025 DENDREON PHARMACEUTICALS, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$59,650
2025 DENDREON PHARMACEUTICALS, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$58,787
2025 DENDREON PHARMACEUTICALS, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$60,147
2024 DENDREON PHARMACEUTICALS, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$67,562
2024 DENDREON PHARMACEUTICALS, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$67,987
2024 DENDREON PHARMACEUTICALS, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$68,072
2024 DENDREON PHARMACEUTICALS, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$67,477
2023 DENDREON PHARMACEUTICALS, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$104,223
Page 1 of 4  ·  32 filings Next

Clients Represented

ClientFilingsTotal Income
DENDREON PHARMACEUTICALS, LLC 32

Lobbyists

NameDisclosed Prior Position
ANDREW SAELENS